Variant report

Variant	nsv961428
Chromosome Location	chr2:87063936-87093055
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:87064398-87064705	K562	blood:	n/a	n/a
2	BATF	chr2:87067239-87067491	GM12878	blood:	n/a	n/a
3	BCL11A	chr2:87067240-87067563	GM12878	blood:	n/a	n/a
4	BCL11A	chr2:87067184-87067494	GM12878	blood:	n/a	n/a
5	BHLHE40	chr2:87073448-87073475	K562	blood:	n/a	n/a
6	BHLHE40	chr2:87064342-87064452	K562	blood:	n/a	n/a
7	BHLHE40	chr2:87085068-87085187	K562	blood:	n/a	n/a
8	BRCA1	chr2:87064342-87064609	Hela-S3	cervix:	n/a	n/a
9	BRCA1	chr2:87083149-87083563	Hela-S3	cervix:	n/a	n/a
10	BRCA1	chr2:87085072-87085563	HepG2	liver:	n/a	n/a
11	CEBPB	chr2:87064408-87064778	IMR90	lung:	n/a	n/a
12	CEBPB	chr2:87064403-87064763	A549	lung:	n/a	n/a
13	CEBPB	chr2:87064442-87064736	K562	blood:	n/a	n/a
14	CEBPB	chr2:87066534-87066731	HepG2	liver:	n/a	chr2:87066589-87066600
15	CEBPB	chr2:87083121-87083433	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr2:87064278-87064778	Hela-S3	cervix:	n/a	n/a
17	CTCF	chr2:87076219-87076280	LNCaP	prostate:	n/a	n/a
18	CTCF	chr2:87084149-87084262	K562	blood:	n/a	n/a
19	CTCF	chr2:87084208-87084277	GM20000	blood:	n/a	n/a
20	CTCF	chr2:87083596-87083657	Kidney_OC	kidney:	n/a	n/a
21	CTCF	chr2:87084533-87084599	GM20000	blood:	n/a	n/a
22	CTCF	chr2:87090002-87090051	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr2:87089612-87089721	H1-hESC	embryonic stem cell:	n/a	chr2:87089697-87089706 chr2:87089644-87089657
24	CTCF	chr2:87091764-87091806	GM10266	blood:	n/a	n/a
25	ELF1	chr2:87083218-87083420	K562	blood:	n/a	chr2:87083341-87083352 chr2:87083341-87083352 chr2:87083339-87083352
26	ELF1	chr2:87083201-87083452	HepG2	liver:	n/a	chr2:87083341-87083352 chr2:87083341-87083352 chr2:87083339-87083352
27	ELF1	chr2:87083229-87083449	HepG2	liver:	n/a	chr2:87083341-87083352 chr2:87083341-87083352 chr2:87083339-87083352
28	ESR1	chr2:87067866-87068195	ECC-1	luminal epithelium:	n/a	chr2:87067981-87067998 chr2:87067980-87067997
29	ESR1	chr2:87067890-87068112	ECC-1	luminal epithelium:	n/a	chr2:87067981-87067998 chr2:87067980-87067997
30	FOS	chr2:87064254-87064772	MCF10A-Er-Src	breast:	n/a	chr2:87064576-87064587 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
31	FOS	chr2:87064028-87064772	MCF10A-Er-Src	breast:	n/a	chr2:87064576-87064587 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
32	FOS	chr2:87064352-87064763	HUVEC	blood vessel:	n/a	chr2:87064576-87064587 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
33	FOS	chr2:87064347-87064769	MCF10A-Er-Src	breast:	n/a	chr2:87064576-87064587 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
34	FOS	chr2:87064399-87064770	MCF10A-Er-Src	breast:	n/a	chr2:87064576-87064587 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
35	FOSL2	chr2:87083131-87083421	HepG2	liver:	n/a	n/a
36	FOSL2	chr2:87064346-87064739	HepG2	liver:	n/a	chr2:87064575-87064586 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
37	FOSL2	chr2:87064272-87064803	A549	lung:	n/a	chr2:87064575-87064586 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
38	FOSL2	chr2:87064318-87064797	HepG2	liver:	n/a	chr2:87064575-87064586 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
39	FOSL2	chr2:87064411-87064650	A549	lung:	n/a	chr2:87064575-87064586 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590
40	FOXA1	chr2:87092952-87093483	HepG2	liver:	n/a	n/a
41	FOXA1	chr2:87085524-87085953	HepG2	liver:	n/a	chr2:87085799-87085811
42	FOXA1	chr2:87083151-87083381	T-47D	breast:	n/a	n/a
43	FOXA2	chr2:87064297-87064844	A549	lung:	n/a	n/a
44	FOXP2	chr2:87083159-87083428	SK-N-MC	brain:	n/a	n/a
45	GTF2F1	chr2:87083148-87083402	Hela-S3	cervix:	n/a	n/a
46	GTF2F1	chr2:87064221-87064720	Hela-S3	cervix:	n/a	n/a
47	GTF2F1	chr2:87083146-87083343	H1-hESC	embryonic stem cell:	n/a	n/a
48	JUN	chr2:87064410-87064697	K562	blood:	n/a	chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590
49	JUN	chr2:87064415-87064816	K562	blood:	n/a	chr2:87064796-87064805 chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699
50	JUND	chr2:87064393-87064768	K562	blood:	n/a	chr2:87064577-87064587 chr2:87064577-87064587 chr2:87064579-87064590 chr2:87064687-87064699

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:87087878-87087928	ECC-1	luminal epithelium:	n/a
2	chr2:87088796-87088846	Jurkat	blood:	n/a
3	chr2:87087878-87087928	ECC-1	luminal epithelium:	n/a
4	chr2:87088796-87088846	Jurkat	blood:	n/a
5	chr2:87088843-87088893	HL-60	blood:	n/a
6	chr2:87088843-87088893	T-47D	breast:	n/a
7	chr2:87090202-87090252	AG10803	skin:	n/a
8	chr2:87069146-87069196	GM12891	blood:	n/a
9	chr2:87087878-87087928	SK-N-SH	brain:	n/a
10	chr2:87092164-87092214	HMEC	breast:	n/a
11	chr2:87089442-87089492	GM19239	blood:	n/a
12	chr2:87088796-87088846	K562	blood:	n/a
13	chr2:87092164-87092214	HL-60	blood:	n/a
14	chr2:87089442-87089492	NH-A	brain:	n/a
15	chr2:87089933-87089983	SK-N-SH	brain:	n/a
16	chr2:87089933-87089983	Jurkat	blood:	n/a
17	chr2:87089442-87089492	PrEC	prostate:	n/a
18	chr2:87088843-87088893	SK-N-MC	brain:	n/a
19	chr2:87085357-87085407	H1-hESC	embryonic stem cell:	embryo
20	chr2:87088843-87088893	SK-N-SH_RA	brain:	n/a
21	chr2:87088796-87088846	HNPCEpiC	eye:	n/a
22	chr2:87069146-87069196	NHDF-neo	bronchial:	n/a
23	chr2:87088834-87088884	LNCaP	prostate:	n/a
24	chr2:87088843-87088893	HRPEpiC	eye:	n/a
25	chr2:87089933-87089983	RPTEC	kidney:	n/a
26	chr2:87090181-87090231	CMK	blood:	n/a
27	chr2:87088843-87088893	Caco-2	colon:	n/a
28	chr2:87088796-87088846	NB4	blood:	n/a
29	chr2:87088834-87088884	SAEC	small airway:	n/a
30	chr2:87088843-87088893	NHDF-neo	bronchial:	n/a
31	chr2:87087878-87087928	HCM	heart:	n/a
32	chr2:87088796-87088846	NH-A	brain:	n/a
33	chr2:87090202-87090252	HEEpiC	esophagus:	n/a
34	chr2:87090181-87090231	T-47D	breast:	n/a
35	chr2:87088796-87088846	GM19239	blood:	n/a
36	chr2:87088834-87088884	AoSMC	blood vessel:	n/a
37	chr2:87089442-87089492	SAEC	small airway:	n/a
38	chr2:87088796-87088846	HEEpiC	esophagus:	n/a
39	chr2:87088817-87088867	SK-N-SH_RA	brain:	n/a
40	chr2:87069146-87069196	GM12892	blood:	n/a
41	chr2:87069146-87069196	AG04449	skin:	fetal
42	chr2:87090181-87090231	HCF	heart:	n/a
43	chr2:87069146-87069196	PFSK-1	brain:	n/a
44	chr2:87088817-87088867	BJ	skin:	n/a
45	chr2:87088817-87088867	AoSMC	blood vessel:	n/a
46	chr2:87089442-87089492	Caco-2	colon:	n/a
47	chr2:87090202-87090252	HPAEpiC	pulmonary alveolar:	n/a
48	chr2:87089933-87089983	HepG2	liver:	n/a
49	chr2:87088796-87088846	ovcar-3	ovarian:	n/a
50	chr2:87090202-87090252	BJ	skin:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:87053953..87055906-chr2:87062095..87066104,3	MCF-7	breast:
2	chr2:87083747..87086629-chr2:107106003..107108745,2	K562	blood:

Variant related genes	Relation type
ENSG00000229615	TF binding region
CD8B	TF binding region
ENSG00000229615	CpG island
CD8B	CpG island

Extended variants
information (count: 1021 )
Associated
traits (count: 50 )

Variant overlapped rSNPs/rCNVs (count:1021 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573739435	chr2:87063943-87063944	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs541032849	chr2:87064026-87064027	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs368713602	chr2:87064027-87064028	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs559389231	chr2:87064030-87064031	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs577585373	chr2:87064043-87064044	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs372355176	chr2:87064044-87064045	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs146984411	chr2:87064069-87064070	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs138057678	chr2:87064179-87064180	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs187465031	chr2:87064192-87064193	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs549517858	chr2:87064201-87064202	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs561054485	chr2:87064230-87064231	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs80288137	chr2:87064237-87064238	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs546635647	chr2:87064271-87064272	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs571298384	chr2:87064288-87064289	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs539749328	chr2:87064292-87064293	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs59909368	chr2:87064302-87064303	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs569898517	chr2:87064440-87064441	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs536865085	chr2:87064446-87064447	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs555556874	chr2:87064477-87064478	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs573829096	chr2:87064482-87064483	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs148213981	chr2:87064511-87064512	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs141159785	chr2:87064521-87064522	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs111975432	chr2:87064531-87064532	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs577687116	chr2:87064541-87064542	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs190707788	chr2:87064580-87064581	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs563840529	chr2:87064600-87064601	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs575851725	chr2:87064661-87064662	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs542855080	chr2:87064680-87064681	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs561141511	chr2:87064713-87064714	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs528602535	chr2:87064734-87064735	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs546672512	chr2:87064798-87064799	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs182958703	chr2:87064810-87064811	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs565010233	chr2:87064872-87064873	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs532417192	chr2:87064921-87064922	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs187964722	chr2:87064933-87064934	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs73947278	chr2:87065012-87065013	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs569856017	chr2:87065014-87065015	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs537351030	chr2:87065054-87065055	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs541559025	chr2:87065067-87065068	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs567455263	chr2:87065096-87065097	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs190401027	chr2:87065122-87065123	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs6740214	chr2:87065173-87065174	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs187423900	chr2:87065208-87065209	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs571284965	chr2:87065285-87065286	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs538263660	chr2:87065317-87065318	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs556866932	chr2:87065342-87065343	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs192223993	chr2:87065390-87065391	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs113771024	chr2:87065431-87065432	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs554776809	chr2:87065461-87065462	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs10204118	chr2:87065523-87065524	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:50)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Lung cancer	18438408	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Schizophrenia	23813976	CNVD
Schizophrenia	20967226	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:301 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:87053400-87066600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr2:87055400-87072600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
3	chr2:87056000-87066600	Enhancers	Fetal Thymus	thymus
4	chr2:87058600-87065800	Enhancers	Primary T cells fromperipheralblood	blood
5	chr2:87059200-87066600	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr2:87060400-87066800	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr2:87060600-87069400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr2:87061000-87066600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr2:87062400-87064000	Enhancers	Thymus	Thymus
10	chr2:87063200-87064200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
11	chr2:87063200-87064400	Enhancers	Primary T killer memory cells from peripheral blood	blood
12	chr2:87063800-87064000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr2:87063800-87064000	Flanking Active TSS	Stomach Smooth Muscle	stomach
14	chr2:87063800-87064200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr2:87063800-87064200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr2:87063800-87064200	Enhancers	Colon Smooth Muscle	Colon
17	chr2:87063800-87064200	Enhancers	Fetal Muscle Trunk	muscle
18	chr2:87063800-87064200	Enhancers	Sigmoid Colon	Sigmoid Colon
19	chr2:87063800-87064400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr2:87063800-87064400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr2:87063800-87064400	Enhancers	Rectal Smooth Muscle	rectum
22	chr2:87063800-87064400	Enhancers	Stomach Mucosa	stomach
23	chr2:87063800-87064400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
24	chr2:87063800-87064600	Enhancers	Primary T cells from cord blood	blood
25	chr2:87063800-87064600	Enhancers	Primary T helper naive cells from peripheral blood	blood
26	chr2:87063800-87065200	Flanking Active TSS	Dnd41	blood
27	chr2:87063800-87065800	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr2:87063800-87066000	Enhancers	Primary monocytes fromperipheralblood	blood
29	chr2:87064000-87064200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr2:87064000-87064200	Enhancers	Muscle Satellite Cultured Cells	--
31	chr2:87064000-87064200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr2:87064000-87064200	Enhancers	Duodenum Smooth Muscle	Duodenum
33	chr2:87064000-87064200	Enhancers	Skeletal Muscle Male	skeletal muscle
34	chr2:87064000-87064200	Flanking Active TSS	Thymus	Thymus
35	chr2:87064000-87064200	Enhancers	A549	lung
36	chr2:87064000-87064200	Enhancers	Hela-S3	cervix
37	chr2:87064000-87064200	Enhancers	NHDF-Ad	bronchial
38	chr2:87064000-87064200	Enhancers	Osteobl	bone
39	chr2:87064000-87064400	Enhancers	Adipose Nuclei	Adipose
40	chr2:87064000-87064400	Enhancers	Fetal Intestine Large	intestine
41	chr2:87064000-87064600	Enhancers	NHEK	skin
42	chr2:87064000-87064800	Active TSS	Stomach Smooth Muscle	stomach
43	chr2:87064000-87065200	Enhancers	Placenta	Placenta
44	chr2:87064000-87065200	Enhancers	HMEC	breast
45	chr2:87064000-87065400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
46	chr2:87064200-87064400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr2:87064200-87064400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr2:87064200-87064400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
49	chr2:87064200-87064400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr2:87064200-87064400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links